Atkinson's Academic Venture Fund awards $1.8M to 15 projects

The Atkinson Center for a Sustainable Future's Academic Venture Fund awarded $1.8 million in 2017, with 15 grants to seed novel approaches to some of the world's greatest sustainability challenges.

Imaging technique shows molecular machinery at work

New imaging methods that allow researchers to track the individual protein molecules on the surface of cells offer unprecedented insight into how cells sense and respond to their environments.

Next generation of health care leaders celebrated June 1

Vibrant red and white bouquets lined the Perelman Stage at Carnegie Hall as degrees were conferred on 275 students graduating from Weill Cornell Medicine June 1.

Study: Ketamine fails to treat pain, can cause hallucinations

A new study suggests that ketamine doesn't lower levels of pain or reduce the need for pain-killing opioid drugs in the days after an operation, has side effect.

Singh wins grant from defense department for cancer research

Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering, has won a $555,000 grant from the defense department to further his study of B-cell lymphoma.

Initiative will connect research across NYC, Ithaca campuses

A new initiative on academic integration will connect research across Weill Cornell Medicine, Cornell Tech and the Ithaca campus. Dr. Gary Koretzky will lead the effort, which will tie together investigation and discovery.

Weill Cornell team creates breakthrough on blood disorders

Researchers at Weill Cornell Medicine have discovered an innovative method to make an unlimited supply of healthy blood cells from the readily available cells that line blood vessels.

'Bookmarks' on stem cell genes preserve cell identity

Stem cells preserve their identities after cell division by using a series of protein "bookmarks" on their genes, according to new research published by scientists at Weill Cornell Medicine.

Researchers ID drug that blocks some blood cancers

A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS.